Myc1, often simply referred to as Myc in many contexts, is a transcription factor that plays a critical role in regulating several cellular processes, including cell growth, proliferation, differentiation, and apoptosis. It is a member of the Myc family of proteins, which are recognized for their helix-loop-helix leucine zipper motif, allowing them to bind DNA and regulate gene expression. Myc1 operates by forming heterodimers with another protein called Max, and this dimerization facilitates the binding of Myc to specific DNA sequences, leading to the modulation of target gene transcription. Given its central role in governing cellular fate, the expression and activity of Myc1 are tightly regulated under normal physiological conditions. However, aberrations in Myc1 function or expression can lead to uncontrolled cell proliferation.
Myc1 Inhibitors represent a specialized class of chemical compounds designed to specifically target and modulate the function of Myc1. These inhibitors function by disrupting the Myc-Max interaction, preventing Myc1 from binding to its target DNA sequences, or interfering with the transcriptional activity of Myc1. By doing so, they can effectively dampen the downstream effects mediated by this transcription factor. The strategic inhibition of Myc1 offers a mechanism to control the myriad cellular processes that it regulates. Given the wide-ranging implications of Myc1 in cell fate decisions and its association with oncogenic transformations, understanding and harnessing the potential of Myc1 inhibitors can provide a deeper insight into the molecular intricacies of cellular regulation and growth control. The study and development of these inhibitors are crucial in the realm of molecular biology and cellular research, offering tools to dissect the nuanced roles of Myc1 in various biological contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
10058-F4 | 403811-55-2 | sc-213577 sc-213577B sc-213577A sc-213577C | 5 mg 10 mg 25 mg 50 mg | $81.00 $134.00 $241.00 $426.00 | 9 | |
Inhibits c-Myc by disrupting its interaction with Max, thereby hindering the formation of the Myc-Max transcriptional activator complex. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Targets BET bromodomains, leading to downregulation of c-Myc expression in some cancer types. | ||||||
KJ Pyr 9 | 581073-80-5 | sc-507276 | 5 mg | $140.00 | ||
Inhibits the interaction between c-Myc and the KIX domain of CBP, affecting c-Myc's transcriptional activity. | ||||||
Myci975 | 2289691-01-4 | sc-507277 sc-507277A sc-507277B | 100 mg 250 mg 1 g | $420.00 $950.00 $3219.00 | ||
Specifically designed to inhibit c-Myc by preventing its transcriptional activation. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
A cyclin-dependent kinase inhibitor, indirectly affects c-Myc stability and activity. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A CDK4/6 inhibitor, can lead to downregulation of c-Myc in certain cell types. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $247.00 $888.00 | 1 | |
A broad CDK inhibitor, indirectly affects c-Myc levels by inhibiting transcriptional regulators. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, can indirectly affect c-Myc expression by altering chromatin structure and gene expression. | ||||||